Sichuan, China

Wang Huang

This inventor holds 14 USPTO granted patents and 1 published patent application and 4 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Sichuan Jiuzhang Biological Science and Technology Co., Ltd., Sichu Jiuzhang Boplogical Science and Technology Co., Ltd.. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wang Huang. Retrieved from https://idiyas.com/inventor/wang-huang-n9b4k9sx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Chlorogenic Acid
Cancer Treatment
Ocular Inflammation
Tumor Multi-Drug Resistance
Kidney Cancer
Sarcoma
Melanoma
Nasal Administration
Pharmaceutical Composition
Preparation Method
Lupus Erythematosus
14 patents (USPTO):Explore Patents

Title: Innovations by Inventor Wang Huang

Introduction

Wang Huang is a notable inventor based in Sichuan, China, recognized for his significant contributions to the field of biological science and technology. With a total of 14 patents to his name, he has made remarkable advancements in the treatment of ocular inflammation and squamous cell carcinoma.

Latest Patents

Wang Huang's latest patents include the use of chlorogenic acid in the preparation of drugs for preventing and treating ocular inflammation. This innovative application demonstrates that chlorogenic acid can significantly alleviate symptoms of uveitis and scleritis, showcasing its effectiveness in treating ocular inflammation. Another notable patent involves the application of chlorogenic acid and compositions thereof in the preparation of drugs for treating squamous cell carcinoma. This patent highlights that chlorogenic acid and/or coumaroylquinic acid can effectively treat squamous cell carcinoma, and their combination can yield a synergistic effect, presenting excellent application prospects.

Career Highlights

Throughout his career, Wang Huang has worked with prominent companies such as Sichuan Jiuzhang Biological Science and Technology Co., Ltd. and Sichuan Jiuzhang Biological Science and Technology Co., Ltd. His work in these organizations has contributed to the development of innovative solutions in the field of biological sciences.

Collaborations

Wang Huang has collaborated with esteemed colleagues, including Jie Zhang and Xiaoguang Chen, to further enhance his research and development efforts.

Conclusion

Wang Huang's innovative work in the field of biological science and technology has led to significant advancements in the treatment of ocular inflammation and squamous cell carcinoma. His contributions continue to impact the medical field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…